Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Rutgers Receives $10 Million Donation for Cancer Research

New Brunswick, NJ, September 9, 2014 ― The Star-Ledger today reports that Rutgers, The State University of New Jersey has received a $10 million anonymous grant to help its scientists discover targeted therapies for hard-to-treat cancers.

The donation, given over two years, will fund everything from clinical trials to undergraduate training in the growing field known as “precision medicine.”

The gift includes support for the advanced genomic analysis of cancers undertaken at RUCDR Infinite Biologics, the repository of cell and DNA tissue samples that is now part of the Rutgers Human Genetics Institute of New Jersey.

It also includes $1 million to underwrite the cost of drafting a new undergraduate curriculum in cancer genetics, along with money to endow two faculty slots.

The money was given by a couple who feel it is important that the state’s residents have top-flight cancer treatment available to them without having to go to New York or Philadelphia, said Nevin Kessler, president of the Rutgers University Foundation.

While Rutgers Cancer Institute of New Jersey is one of only 41 federally designated centers in the country, “because we have New York and Philadelphia at our doorstep, we can be overshadowed,” Kessler said.

The anonymous couple, one of whom is a Rutgers alum, also has a strong interest in science. “This gift was really guided by their interest and passion,” Kessler said.

To read the full Star-Ledger story, click here.